John Kerins

John Kerins is a Director in Cain Brother’s Corporate M&A Advisory practice. Mr. Kerins joined Cain Brothers in 2015 with 10+ years of experience in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Kerins’ notable transactions since joining Cain Brothers include the minority recapitalization of RedCard by Parthenon Capital Partners, the sale of iCardiac Technologies to ERT, the recapitalization of Steward Health Care System with Medical Properties Trust, the sale of Onlife to Guidewell, Morgan Stanley Capital Partners’ acquisition of Clarity, advising Premier Healthcare Exchange and Pay-Plus Solutions on their merger with Stratose, and BioScrip’s PIPE offering to Coliseum Capital Management. Prior to joining Cain Brothers, Mr. Kerins was a Vice President at Deloitte Corporate Finance LLC, where he focused on mergers, acquisitions, and fairness opinions across a variety of sectors. Mr. Kerins’ prior experience also includes working for McMaster-Carr Supply Company, a privately held distributor, in a variety of management capacities, including operations and sales management. Mr. Kerins earned a BA in Political Science from Kenyon College and an MBA from Fordham University.

Filter and Search Posts
Filter Insights By:
Show Results
Search Insights
The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast
COVID-19 is the most deadly and confounding world health crisis since the 1918 influenza pandemic which killed as… Read More
By and November 23, 2020
Commercializing Breakthrough Drugs In a Value-Based Market
Key Takeaways: Society demands both innovation and fair pricing from drug companies that develop treatments for all diseases…. Read More
By and December 10, 2019